Baseline characteristics

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors · Source last updated 2025-02-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      98

   2. group Id

      BG001

      value

      105

   3. group Id

      BG002

      value

      203

   units

   Participants

groups

1. description

   Patients receive 4 courses of bleomycin, etoposide, and cisplatin (BEP). bleomycin sulfate: At least one course administered cisplatin: At least one course administered etoposide: At least one course administered

   id

   BG000

   title

   Arm I

2. description

   Patients receive 1 course of bleomycin, etoposide, and cisplatin (BEP). Patients then receive dose-dense sequential combination chemotherapy comprising cisplatin, etoposide, bleomycin, paclitaxel, oxaliplatin, and ifosfamide. bleomycin sulfate: At least one course administered cisplatin: At least one course administered etoposide: At least one course administered ifosfamide: Given in a dose-dense sequential fashion oxaliplatin: Given in a dose-dense sequential fashion paclitaxel: Given in a dose-dense sequential fashion

   id

   BG001

   title

   Arm II

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            lower Limit

            17

            upper Limit

            65

            value

            27

         2. group Id

            BG001

            lower Limit

            16

            upper Limit

            51

            value

            30

         3. group Id

            BG002

            lower Limit

            16

            upper Limit

            65

            value

            30

   dispersion Type

   FULL_RANGE

   param Type

   MEDIAN

   title

   Age, Continuous

   unit Of Measure

   Years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            98

         2. group Id

            BG001

            value

            105

         3. group Id

            BG002

            value

            203

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            10

         2. group Id

            BG001

            value

            9

         3. group Id

            BG002

            value

            19

      title

      United States

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            9

         2. group Id

            BG001

            value

            9

         3. group Id

            BG002

            value

            18

      title

      Slovakia

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            79

         2. group Id

            BG001

            value

            87

         3. group Id

            BG002

            value

            166

      title

      France

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice